Menu

Top Stories

Published on Thursday, April 11, 2019

Moderated discussion: “Advancing the innovation ecosystem: Working together for patients,” in Washington, DC

Moderated discussion: “Advancing the innovation ecosystem: Working together for patients,” in Washington, DC

On April 3, 2019, Francis Collins, MD, PhD, director of the National Institutes of Health (NIH), Mikael Dolsten, MD, PhD, chief scientific officer and president, Worldwide Research, Development and Medical, Pfizer, joined in a discussion led by Susan Dentzer, visiting fellow at the Robert J. Margolis Center for Health Policy, Duke University, in Washington DC.

Photo: Francis Collins, MD, PhD, director of the NIH (left) and author Alejandro Hernandez, editorial manager of the Alpha-1 Foundation (right)

For 60 minutes, Collins, Dolsten, and Dentzer engaged in a conversation with the theme of: “Advancing the innovation ecosystem: working together for patients,” where they emphasized the need for continued collaboration between the private and public sectors, along with the patient community, in order to advance new and emerging technologies and innovative approaches for potentially life-saving treatments and new outcomes in medicine.

“We are currently living in remarkable times with amazing things happening in areas such as cancer immuno-therapy, gene therapy, and gene editing. The things that are happening right now, I had no idea they would even be possible just five or six years ago,” expressed Collins when asked about the current position “the ecosystem,” as they described the collaboration between the private and public sectors with small biotech companies; an ecosystem with symbiotic characteristics where all contributors play an important role in a tremendous team effort, in medical research.

Collins and Dolsten agreed on the importance of advocacy groups and organizations as well as the patient community, in being part of the process for better outcomes and the ability to bring new and potential treatments for various conditions to the clinic, including rare diseases, such as Alpha-1 Antitrypsin Deficiency (Alpha-1). 

“We need you, the patient community, you are the reason we have gotten this far,” said Collins.

“One of the most important resources needed for this ecosystem to strive is you, the patient. We need to line-up our resources and keep the ecosystem going, including the patient community. There is no one better to bring together what others (physicians) can do than patients: you inspire all of us,” expressed Dolsten.

The Alpha-1 Foundation applauds and supports these types of initiatives, in which patients become partners and are of vital importance for therapeutic development. 

The panel also mentioned that it is critical to spread awareness and education in the medical community, and being able to have early diagnosis and detection, while mentioning the Accelerating Medicines Partnership (AMP), a public-private partnership between the NIH, the U.S. Food and Drug Administration (FDA), multiple biopharmaceutical, and life science companies, as well as non-profit organizations to transform the current model for developing new diagnostics and treatments by jointly identifying and validating promising biological targets for therapeutics.

The ultimate goal of AMP is to increase the number of new diagnostics and therapies for patients and reduce the time and cost of developing them.

“Patient participation is critical for AMP, especially to remind us what we are doing and why-and-who we are doing it for,” said Collins, who also mentioned the Foundation for the National Institutes of Health (FNIH) as being instrumental in bringing together funds and resources from both the private and public sectors, to work in mutual collaboration in research projects that will ultimately benefit the patient community.

The Alpha-1 Foundation applauds these types of initiatives that support research and bring innovative approaches to the table for the benefit of the patient community, as we are committed to finding a cure for Alpha-1 and improving the lives of Alphas, and those affected by the condition, worldwide.

For more information, please visit the Collaboration Ecosystem website and the AMP website.


Print

Karen Erickson to lead operations in TAP

Wednesday, October 24, 2018
The Alpha-1 Project (TAP) announces the appointment of Karen Erickson as Chief Operating Officer, a new position within TAP. The appointment is effective November 1, 2018. Erickson leaves her position as Associate Executive Director for...
Divider

Escape to the Cape was a total success for Alpha-1

Monday, October 22, 2018
A weekend in the scenic coast of Cape Cod, Massachusetts, with bike riding and lots of family fun was the perfect setting for this year’s Escape to the Cape Bike Trek, in which Team Alpha-1 raised $100,000 for Alpha-1 Antitrypsin Deficiency...
Divider

CMS announces premiums and deductibles for Medicare and exchanges drop in 2019

Monday, October 15, 2018
2019 Medicare Parts A & B Premiums and Deductibles Last week, the Centers for Medicare & Medicaid Services (CMS) released the 2019 premiums, deductibles, and coinsurance amounts for the Medicare Part A and Part B programs. Medicare Part...
Divider

Drug pricing bills get signed and more will come

Friday, October 12, 2018
This week, the Know the Lowest Price Act and the Patients’ Right to Know Drug Prices Act were signed by President Trump. The measure received overwhelming bipartisan approval in Congress and was part of Trump’s drug-pricing...
Divider

Alpha leader Sally Everett passes away

Thursday, October 11, 2018
It is with great sadness and a heavy heart that the Alpha-1 Foundation announces the passing of Sarah E. (Sally) Everett, on October 10th, 2018, at age 75. Sally was an attorney for the New York state attorney general’s Medicaid Fraud...
Divider

Alpha-1 Foundation supports letters to the U.S. Department of Health and Human Services on Step Therapy

Wednesday, October 10, 2018
The National Health Council (NHC), the American Cancer Society Cancer Action Network (ACS CAN) and several patient-advocacy organizations, including the Alpha-1 Foundation, sent a letter to Alex M. Azar II, secretary of the U.S. Department of...
Divider

Gene-silencing therapy (RNAi) is on the move

Tuesday, October 9, 2018
“The recent announcements by Alnylam Pharmaceuticals and Arrowhead Pharmaceuticals are excellent news for our patients. Both companies are developing therapies for the liver by ‘silencing’ the production of the alpha-1...
Divider

Officials warn about respiratory complications from red tide

Tuesday, October 9, 2018
A red tide, or harmful algal bloom, is a higher-than-normal concentration of a microscopic alga (plantlike organism). In Florida and the Gulf of Mexico, the species that causes most red tides is Karenia brevis, often abbreviated as K. brevis. To...
Divider

Antibacterial drug for rare lung disease gets approved

Monday, October 8, 2018
The U.S. Food and Drug Administration (FDA) approved a new drug, Arikayce (amikacin liposome inhalation suspension), for the treatment of lung disease caused by a group of bacteria, Mycobacterium avium complex (MAC) in a limited population of...
Divider

Health officials urge people to get the flu shot

Friday, October 5, 2018
U.S. Health Officials are urging the general population to get vaccinated for the flu this year after a severe outbreak killed a record number of children and led to shortages of antiviral medications, last season. In a panel hosted by the...
Divider

Dohman Life Science Services to be renamed to EVERSANA

Thursday, October 4, 2018
The fast-growing life science services platform built in partnership with Water Street Healthcare Partners and JLL Partners unveiled its new name and brand: EVERSANA™. A combination of the Latin word "sana" for healthy and...
Divider

Medicare Open Enrollment for 2019 Webinar

Wednesday, October 3, 2018
Save the Date!   Medicare Open Enrollment for 2019 Webinar Thursday, October 18th 4:00 PM ET (3 PM CT; 2 PM MT; 1 PM PT) Speaker: Tim Boyd, MPH Director of State Policy with National Organization for Rare Disorders...
Divider
First234567891011Last

Article Search

Enter keywords in text box and click Search button for results.

Archive